DRIVE-AB retweeted
Are you following our @jac_amr account yet? Our fully #OpenAccess journal is the best place for all things related to #AMR and #AntibioticStewardship!
DRIVE-AB retweeted
Our @DRIVE_AB project's final report recommends a mix of push & pull incentives to stimulate #antibiotic development.
Read the report https://xitter.gq/t.co/pGLIaTjN6e
Read the project's press release https://xitter.gq/t.co/nzfqulB2r6
#AntimicrobialResistance #CarryTheTorch #InvestEUresearch
DRIVE-AB retweeted
Want to meet #AMR experts to discuss how to further support #SME-driven innovation in the fight against #AntibioticResistance? Register now for #BerlinConference in March 2018: berlin-conferences.com/home/ @UU_University @BachmannTill @EdinburghUni @DRIVE_AB @ND4BB_ENABLE
DRIVE-AB retweeted
How should a market entry reward for new antibiotics look like? David Findlay @GSK presents the recommendations from @DRIVE_AB. #DRIVEAB2017
DRIVE-AB retweeted
Incredible news for the global campaign against #AntibioticResistance #AMR @DRIVE_AB @DukeGHI @CIDRAP_ASP xitter.gq/koutterson/status/9050…
90% global population covered today by national action plans for AMR @Marcsprenger4PH @DRIVE_AB
DRIVE-AB retweeted
How can young people help tackle antibiotic resistance?Join us at #Expo17NHS next week and we'll explain all: ow.ly/scmH30eMKSH #AMR
DRIVE-AB retweeted
Dominique Monnet: caz-avi should not be used unless infection R to other drugs + advised to prescribe by micro/ID specialist #DRIVEAB2017
DRIVE-AB retweeted
'Health technology assessments (HTA) must include sensitivity analysis of the impact of resistance to the new abx’: CDDEP Dir. R Laxminaryan xitter.gq/CDDEP/status/905332590…
CDDEP’s Ramanan Laxminarayan @DRIVE_AB: "Antibiotics are treated like any other drug. No specific guidelines."
DRIVE-AB retweeted
Pillars also interpreted as innovation, access and sustainability @DRIVE_AB xitter.gq/laurapiddock/status/90…
Pillars of @DRIVE_AB on which research has built - access to antibiotics, infection control and conservation of drugs #DRIVEAB2017
DRIVE-AB retweeted
@ND4BB_ENABLE Pierre Meulien presents ND4BB and ENABLE #DRIVEAB2017
DRIVE-AB retweeted
Replying to @Marcsprenger4PH @DRIVE_AB
Real consensus on these complex issues requires time; thank you @Drive_AB for getting the conversation started. This work must continue!
DRIVE-AB retweeted
Sharon Brennan - CF sufferer - living with drug-resistant infections. Advice: take responsibility for your own health and prevent infections
DRIVE-AB retweeted
Man-Wah described up to 20 abx in a mAb conjugate @DRIVE_AB xitter.gq/southafricanasp/status… – at Sint-Joost-ten-Node, België
Antibody-antibiotic conjugates as a novel scientific approach to treat bacteria presented @DRIVE_AB final conference
DRIVE-AB retweeted
To fight #AntibioticResistance WHO partnered with @DNDi to set up the Global Antibiotic R&D Partnership https://xitter.gq/t.co/p0UgKuczCd
DRIVE-AB retweeted
90% global population covered today by national action plans for AMR @Marcsprenger4PH @DRIVE_AB
DRIVE-AB retweeted
I've also posted an updated master list of upcoming AMR-related events: amr.solutions/blog/upcoming-…. Bad bugs are advancing. Let's get busy!
DRIVE-AB retweeted
Replying to @WHO
@WHO has released guidelines on integrated AMR surveillance using a One Health approach! Great news for tackling AMR antibiotic-action.com/who-re…
DRIVE-AB retweeted
G20 Health Ministers Points Out @jpiamr as Key Initiative to Support - very proud moment to be Chair of the JPIAMR SAB 😀
DRIVE-AB retweeted
If you haven't already please take a moment to complete a short survey about topical use of #antibiotics in surgery bsac.org.uk/the-use-of-topic…



























